Paper28899790
Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy.
Schiavone M and 7 others. Pharmacol Res, 2017. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy. Papers, record 28899790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28899790
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclosporine | Major topic |
| Mitochondria | Major topic |
| Muscular Dystrophy, Animal | Major topic |
| Muscular Dystrophy, Duchenne | Major topic |
| Animals | |
| Cell Respiration | |
| Cells, Cultured | |
| Disease Models, Animal | |
| Humans | |
| Membrane Potential, Mitochondrial | |
| Muscle Cells | |
| Oxygen Consumption | |
| Zebrafish |
Source PubMed
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41009414 | VBIT-4 Rescues Mitochondrial Dysfunction and Reduces Skeletal Muscle Degeneration in a Severe Model of Duchenne Muscular Dystrophy. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009414 | PubMed |
| 41009401 | Zebrafish as a Model Organism for Research in Rare Genetic Neuromuscular Diseases. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009401 | PubMed |
| 40757564 | The Role of Mitochondria in Mediation of Skeletal Muscle Repair. | Muscles | 2023 | https://conductscience.org/library/papers/40757564 | PubMed |
| 39337383 | Reduction of Mitochondrial Calcium Overload via MKT077-Induced Inhibition of Glucose-Regulated Protein 75 Alleviates Skeletal Muscle Pathology in Dystrophin-Deficient mdx Mice. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337383 | PubMed |
| 39312281 | Evaluating the potential of non-immunosuppressive cyclosporin analogs for targeting Toxoplasma gondii cyclophilin: Insights from structural studies. | Protein Sci | 2024 | https://conductscience.org/library/papers/39312281 | PubMed |
| 39056750 | Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response. | Cells | 2024 | https://conductscience.org/library/papers/39056750 | PubMed |
| 39045055 | Cyclophilin inhibition as a strategy for the treatment of human disease. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39045055 | PubMed |
| 38607013 | Mitochondria and Reactive Oxygen Species: The Therapeutic Balance of Powers for Duchenne Muscular Dystrophy. | Cells | 2024 | https://conductscience.org/library/papers/38607013 | PubMed |
| 38564291 | Improved mitochondrial function in the hearts of sarcolipin-deficient dystrophin and utrophin double-knockout mice. | JCI Insight | 2024 | https://conductscience.org/library/papers/38564291 | PubMed |
| 38540736 | Mitochondrial Transplantation Therapy Ameliorates Muscular Dystrophy in mdx Mouse Model. | Biomolecules | 2024 | https://conductscience.org/library/papers/38540736 | PubMed |
| 37892218 | Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies. | Biomolecules | 2023 | https://conductscience.org/library/papers/37892218 | PubMed |
| 37628888 | Modeling Sarcoglycanopathy in Danio rerio. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37628888 | PubMed |
| 37600514 | Current and future therapeutic strategies for Alzheimer's disease: an overview of drug development bottlenecks. | Front Aging Neurosci | 2023 | https://conductscience.org/library/papers/37600514 | PubMed |
| 37569848 | New Clinical and Immunofluoresence Data of Collagen VI-Related Myopathy: A Single Center Cohort of 69 Patients. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569848 | PubMed |
| 37511242 | Human Mutated MYOT and CRYAB Genes Cause a Myopathic Phenotype in Zebrafish. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511242 | PubMed |
| 37176020 | Modeling Human Muscular Dystrophies in Zebrafish: Mutant Lines, Transgenic Fluorescent Biosensors, and Phenotyping Assays. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37176020 | PubMed |
| 36768550 | Ion Channels of the Sarcolemma and Intracellular Organelles in Duchenne Muscular Dystrophy: A Role in the Dysregulation of Ion Homeostasis and a Possible Target for Therapy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768550 | PubMed |
| 36613804 | Mechanisms of Myofibre Death in Muscular Dystrophies: The Emergence of the Regulated Forms of Necrosis in Myology. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36613804 | PubMed |
| 36142572 | The Effect of Uridine on the State of Skeletal Muscles and the Functioning of Mitochondria in Duchenne Dystrophy. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142572 | PubMed |
| 35501648 | Effect of Alisporivir on Calcium Ion Transport and Mitophagy in Skeletal Muscle and Heart Mitochondria in Dystrophin-Deficient Mice. | Bull Exp Biol Med | 2022 | https://conductscience.org/library/papers/35501648 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28899790
GET https://conductscience.org/api/papers/v1/28899790/cited_by?page=2